|
V87650
|
(R,R)-PCSK9 degrader 1
|
2216703-12-5 |
(R,R)-PCSK9 degrader 1 is an isomer of PCSK9 degrader 1. |
|
V87653
|
AZD8233
|
2604215-74-7 |
AZD8233 is a liver-targeting antisense oligonucleotide that inhibits proprotein convertase/subtilisin 9 (PCSK9) protein synthesis. |
|
V87655
|
AZD8233 sodium
|
|
AZD8233 sodium is a liver-targeted antisense oligonucleotide that inhibits proprotein convertase/subtilisin/kexin type 9 (PCSK9) protein synthesis. |
|
V87646
|
Cepadacursen sodium
|
2252375-14-5 |
Cepadacursen sodium is a liver-targeted antisense oligonucleotide that inhibits proprotein convertase/subtilisin/kexin type 9 (PCSK9) protein synthesis. |
|
V87648
|
CVI-LM001
|
|
CVI-LM001 is a PCSK9 inhibitor that regulates the level of low-density lipoprotein cholesterol (LDL-C) in the blood by inhibiting the interaction between PCSK9 and low-density lipoprotein receptor (LDLR), thereby exerting a lipid-lowering effect. |
|
V87324
|
DC371739
|
2135765-21-6 |
DC371739 is a potent, orally active PCSK9 inhibitor. |
|
V87654
|
E28362
|
930017-01-9 |
E28362 is a small molecule PCSK9 inhibitor. |
|
V87649
|
PCSK9-IN-26
|
3033361-09-7 |
PCSK9-IN-26 (Compound 116) is a PCSK9 inhibitor (IC50 < 1 nM). |
|
V87651
|
PCSK9-IN-27
|
|
PCSK9-IN-27 (Compound 108) is a PCSK9 inhibitor (IC50: 3.4 nM). |
|
V87652
|
PCSK9-IN-28
|
|
PCSK9-IN-28 (Compound C11) is a PCSK9 inhibitor isolated from Euphorbia esula. |
|
V6648
|
PF-00932239 (R-IMPP)
|
2133832-83-2 |
PF-00932239 (R-IMPP) is a novel and potent inhibitor of PCSK9 translation. |
|
V27359
|
PF-06446846 hydrochloride
|
1632250-50-0 |
PF‑06446846 HCL (PF-6446846;PF6446846) is a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor with anti-hyperlipidemic effects. |
|
V2106
|
SBC-110736
|
1629166-02-4 |
SBC-110736 (SBC110736) is a novel and potent small molecule inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9) with anti-hyperlipidemic effects. |
|
V1879
|
SBC-115076
|
489415-96-5 |
SBC-115076 (SBC115076) is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist, with the potentialfor the treatment and/or prevention of cardiovascular diseases. |
|
V87645
|
SPC5001 sodium
|
|
SPC5001 sodium is a locked nucleic acid (LNA) modified antisense oligonucleotide (ASO) complementary to human PCSK9 (proprotein convertase subtilisin/kexin type 9) mRNA. |
|
V87647
|
SS(no Galnac)-Inclisiran sodium
|
|
SS(no Galnac)-Inclisiran (sodium) is a positive strand of inclisiran without GalNAc modification. |